Ameritas Advisory Services’s Gilead Sciences GILD Stock Holding History

Ameritas Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Sell	8,328 -6,397	-43%	-$896K	0.05%	337
2025 Q4	$1.81M	Buy	14,725 +12,841	+682%	+$1.56M	0.07%	242
2025 Q3	$209K	Sell	1,884 -3,608	-66%	-$410K	0.01%	605
2025 Q2	$609K	Buy	5,492 +616	+13%	+$65.6K	0.03%	457
2025 Q1	$511K	Buy	4,876 +96	+2%	+$9.91K	0.02%	563
2024 Q4	$442K	Sell	4,780 -760	-14%	-$68.4K	0.02%	622
2024 Q3	$464K	Buy	5,540 +348	+7%	+$26.6K	0.02%	560
2024 Q2	$356K	Sell	5,192 -2,167	-29%	-$145K	0.01%	683
2024 Q1	$518K	Buy	7,359 +1,474	+25%	+$113K	0.02%	545
2023 Q4	$461K	Buy	5,885 +177	+3%	+$13.8K	0.03%	445
2023 Q3	$428K	Buy	+5,708	New	+$439K	0.02%	539
2023 Q2	–	Sell	-7,564	Closed	-$647K	–	1337
2023 Q1	$647K	Sell	7,564 -3,369	-31%	-$279K	0.03%	421
2022 Q4	$939K	Buy	10,933 +2,052	+23%	+$162K	0.04%	367
2022 Q3	$548K	Buy	8,881 +585	+7%	+$36.9K	0.03%	410
2022 Q2	$513K	Buy	8,296 +46	+0.6%	+$2.85K	0.03%	445
2022 Q1	$490K	Buy	8,250 +1,044	+14%	+$66.7K	0.02%	506
2021 Q4	$523K	Buy	+7,206	New	+$496K	0.02%	493

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ameritas Advisory Services's GILD Position: Q1 2026 in Review

Ameritas Advisory Services reduced its Gilead Sciences (GILD) stake by 43% in Q1 2026, selling an estimated $896K and leaving 8,328 shares worth $1.16M. The position accounts for 0.05% of the portfolio, ranked #337.

Ameritas Advisory Services first reported a position in GILD in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.81M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Ameritas Advisory Services held 8,328 shares of Gilead Sciences worth $1.16M as of Q1 2026.
Ameritas Advisory Services sold 6,397 Gilead Sciences shares in Q1 2026, an estimated $896K.
Gilead Sciences made up 0.05% of Ameritas Advisory Services's portfolio in Q1 2026, its #337 holding.
Ameritas Advisory Services first reported a position in Gilead Sciences in Q4 2021 and has held it in 17 quarters since.
Ameritas Advisory Services's Gilead Sciences position peaked at $1.81M in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.